Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Pedestrian Crash on Giant Road


Victim Hit by Vehicle in Fatal San Pablo Accident

San Pablo, CA (April 3, 2020) – A man was killed in a pedestrian crash in San Pablo. The fatal accident occurred on the evening of April 3 on Giant Road.

A vehicle hit a man who was crossing in the 2800 block of Giant Road. The man died at the accident scene. The driver remained at the crash site.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Pablo

#94806


March 31, 2020

Desmond King Killed, 3 Injured in Crash on Bancroft Avenue

Driver Arrested for DUI in Fatal Oakland Fresno Accident...


December 4, 2019

1 Injured in Crash on Interstate 280 Under Interstate 880 Overpass

3 Vehicles Involved in San Jose Accident...


April 23, 2020

Angelique Starks, Dog Killed in Crash at 25th and Dakota Streets

SUV Crashes Into Fence, Drops Down Hill in Fatal San Francisco Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.